
Sign up to save your podcasts
Or


The Fierce Pharma Marketing team publishes a special report each year on the top pharmaceutical drug ad spenders. This year’s report, which includes numbers for 2023, was published on Monday.
AbbVie was the standout in this edition, having spent heavily on ads for Skyrizi and Rinvoq. Overall spending on the top 10 ads also experienced a sizable increase compared to the previous year.
In this week’s episode of “The Top Line,” Fierce Pharma Marketing Senior Editor Ben Adams and Deputy Editor Andrea Park discuss the report, providing key insights and takeaways.
To learn more about the topics in this episode:
The top 10 pharma drug ad spenders for 2023
See omnystudio.com/listener for privacy information.
By Fierce Life Sciences4.1
1212 ratings
The Fierce Pharma Marketing team publishes a special report each year on the top pharmaceutical drug ad spenders. This year’s report, which includes numbers for 2023, was published on Monday.
AbbVie was the standout in this edition, having spent heavily on ads for Skyrizi and Rinvoq. Overall spending on the top 10 ads also experienced a sizable increase compared to the previous year.
In this week’s episode of “The Top Line,” Fierce Pharma Marketing Senior Editor Ben Adams and Deputy Editor Andrea Park discuss the report, providing key insights and takeaways.
To learn more about the topics in this episode:
The top 10 pharma drug ad spenders for 2023
See omnystudio.com/listener for privacy information.

3,232 Listeners

1,727 Listeners

4,416 Listeners

2,174 Listeners

385 Listeners

1,983 Listeners

353 Listeners

1,657 Listeners

152 Listeners

99 Listeners

3,979 Listeners

1,447 Listeners

337 Listeners

35 Listeners

171 Listeners